David L.
About David L.
David L. is the Director of R&ED IT Solution Architecture at Bristol Myers Squibb, with expertise in cloud solutions and digital capability management for pharmaceutical R&D.
Current Position at Bristol Myers Squibb
David L. is currently serving as the Director of R&ED IT Solution Architecture at Bristol Myers Squibb. In this role, he leads efforts to design and implement IT solution architectures that enhance research and development capabilities. His position involves streamlining processes and improving the efficiency of R&D operations through innovative IT solutions.
Previous Experience in Pharmaceutical IT
David L. has an extensive background in pharmaceutical IT, previously working at Bristol Myers Squibb as the Associate Director of R&ED IT Digital Capability Management from 2020 to 2022. Before this, he was the Associate Director of R&D Cloud Solutions at Celgene from 2019 to 2020. These roles have equipped him with significant expertise in cloud solutions tailored for research and development, as well as experience in integrating digital capabilities.
Educational Background
David L. holds an Executive MBA from The Wharton School, completed between 2021 and 2023. He also earned a Bachelor of Science (BS) from UC San Diego. This academic background has provided him with a strong foundation in business management and scientific knowledge, complementing his extensive professional experience in IT and pharmaceutical research and development.
Expertise in IT Solution Architecture
David L. has demonstrated significant expertise in IT solution architecture, particularly for research and development in the pharmaceutical industry. At Bristol Myers Squibb, he led the implementation of a new IT solution architecture that improved R&D processes. His work focuses on creating and managing IT strategies that drive operational efficiency and support complex research initiatives.
Integration of Digital Capabilities
David L. has played a crucial role in incorporating digital capabilities into the R&D processes at Bristol Myers Squibb. His efforts in this area have been instrumental in enhancing the technological framework that supports pharmaceutical research, allowing for more efficient data management and process automation. His contributions have been key to modernizing and streamlining R&D operations.